Crossmark

Simultaneous development of zanubrutinib in the USA and China

Crossref DOI link: https://doi.org/10.1038/s41571-020-0414-y

Published Online: 2020-07-10

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Guanqiao https://orcid.org/0000-0002-3626-7220
Liu, Xiaozhen

Chen, Xiaoyuan https://orcid.org/0000-0002-3379-3444
License Information

Text and Data Mining valid from 2020-07-10

Version of Record valid from 2020-07-10
More Information

Article History

First Online: 10 July 2020

Competing interests

: The authors declare no competing interests.